Common use of Clinical Development Program Clause in Contracts

Clinical Development Program. MERCK may, at its sole discretion, undertake, and shall solely own the results of, the Clinical Development Program. MERCK shall have the sole responsibility to make any and all regulatory filings for Compound and Product in the Territory as MERCK, in its sole discretion, deems appropriate, and MERCK shall be the sole owner of all regulatory submissions and government approvals therefor. Similarly, MERCK shall have and conduct any and all communications and interactions with regulatory agencies with respect to the Compound and Product, including without limitation Regulatory Authorities, and other government authorities. ISIS shall cooperate with MERCK in all of these activities whenever and to the extent requested by MERCK, and shall supply MERCK with any and all information necessary or useful to MERCK in preparing and filing regulatory and other government submissions, and in obtaining regulatory and other governmental approvals.